U.S.

Disease Management Employee Benefits Health Care Insurance Multiemployer Prescription Drugs Public Plans U.S.

Multiemployer Plan and Public Employer Coverage of GLP-1 Drugs
Cara McMullin
 

New Survey Data Reveals Total Reported Annual Claim Representation for GLP-1 Drugs for Weight Loss Is Almost Ten Percent A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer and plan sponsor coverage surrounding glucagon-like peptide-1 […]

Continue Reading....
Defined Benefit (DB) Plans DOL Employee Benefits Investments Multiemployer Pensions Retirement U.S.

The Multiemployer Retirement Plan Landscape: DB Takeaways
Justin Held, CEBS
 

According to recent data from Horizon Actuarial Services, LLC and the International Foundation of Employee Benefit Plans, the fifteen-year period between 2006 and 2020 was turbulent for multiemployer defined benefit (DB) pension plans. Financial markets were volatile, and 2008 saw the biggest […]

Continue Reading....
401(k) Plans Compliance DOL Employee Benefits ERISA ERISA50 Legislative Pensions Retirement U.S.

The DOL Retirement Security Final Rule: Highlights for Plan Sponsors
Jenny Gartman, CEBS
 

On April 25, 2024, the Department of Labor (DOL) published the retirement security final rule defining fiduciary status for investment advice to retirement investors under the Employee Retirement Income Security Act (ERISA) and the Internal Revenue Code (IRC). It is set to […]

Continue Reading....
Disease Management Employee Benefits Health Care Mental Health U.S.

Health Plan Oncology Offerings—Designing the Best Possible Benefit
Anne Newhouse, CEBS
 

In recent years, various sources including SunLife and the Business Group on Health have reported that cancer leads high-cost health claims for self-funded plans. Claims data shows the top three diagnoses currently driving claims are cancer, cardiovascular and musculoskeletal diseases. It’s no […]

Continue Reading....